Navigenics Lowers Health Compass Price to $1K
July 22, 2009
Navigenics Lowers Health Compass Price to $1K
Navigenics has lowered the price of its full genetic screening service, Health Compass, from $2,500 to $999.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- With Decode Purchase, Amgen Gains Genetics Expertise, Consumers Lose DTC Testing Option
December 12, 2012 / Pharmacogenomics Reporter - FDA Warns DTC Genomics Firms that Genetic Tests are Not LDTs, May Need Clearance or Approval
June 16, 2010 / Pharmacogenomics Reporter - Will 2009 Be Remembered as the Year Personalized Medicine Went Mainstream?
January 13, 2010 / Pharmacogenomics Reporter - Illumina Delivers Personal Genome Sequencing Results to First Consumer: Amadeus Capital's Hauser
September 2, 2009 / Pharmacogenomics Reporter - Navigenics Adds New Health Conditions to Health Compass
June 17, 2009 / Pharmacogenomics Reporter